The Zurich Heart House would like to invite you to a special webinar on
Cardiorenal Protection in Heart Failure: Role of SGLT2 Inhibition
Date: Thursday, May 5th, 2022, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Thomas F. Lüscher, Zurich and London
Roger Hullin, Lausanne
Moderation: Roger Hullin, Lausanne and Thomas F. Lüscher, London/Zurich
|17:05||Lessons learned from DAPA-HF and DAPA-CKD||Michael Böhm, Homburg/Saar|
|17:25||Cardiorenal benefits: what’s relevant for the cardiologist||Wilfried Mullens, Genk|
|17:45||SGLT2i in Heart Failure: how to implement guidelines into clinical practice||Mark Petrie, Glasgow|
|18:30||End of symposium|
This programme is supported by AstraZeneca.
The scientific programme has not been influenced in any way by its sponsor.